Bay of Plenty Times
  • Bay of Plenty Times home
  • Latest news
  • Business
  • Opinion
  • Lifestyle
  • Property
  • Sport
  • Video
  • Death notices
  • Classifieds

Subscriptions

  • Herald Premium
  • Viva Premium
  • The Listener
  • BusinessDesk

Sections

  • Latest news
  • On The Up
  • Business
  • Opinion
  • Lifestyle
  • Property
    • All Property
    • Residential property listings
  • Rural
    • All Rural
    • Dairy farming
    • Sheep & beef farming
    • Horticulture
    • Animal health
    • Rural business
    • Rural life
    • Rural technology
  • Sport

Locations

  • Coromandel & Hauraki
  • Katikati
  • Tauranga
  • Mount Maunganui
  • Pāpāmoa
  • Te Puke
  • Whakatāne
  • Rotorua

Media

  • Video
  • Photo galleries
  • Today's Paper - E-Editions
  • Photo sales
  • Classifieds

Weather

  • Thames
  • Tauranga
  • Whakatāne
  • Rotorua

NZME Network

  • Advertise with NZME
  • OneRoof
  • Driven Car Guide
  • BusinessDesk
  • Newstalk ZB
  • Sunlive
  • ZM
  • The Hits
  • Coast
  • Radio Hauraki
  • The Alternative Commentary Collective
  • Gold
  • Flava
  • iHeart Radio
  • Hokonui
  • Radio Wanaka
  • iHeartCountry New Zealand
  • Restaurant Hub
  • NZME Events

SubscribeSign In
Advertisement
Advertise with NZME.
Home / Bay of Plenty Times

Kadcyla: Funding after Tauranga woman's fight for cancer wonder-drug

Kiri Gillespie
By Kiri Gillespie
Assistant News Director and Multimedia Journalist·Bay of Plenty Times·
8 Aug, 2019 05:34 AM3 mins to read

Subscribe to listen

Access to Herald Premium articles require a Premium subscription. Subscribe now to listen.
Already a subscriber?  Sign in here

Listening to articles is free for open-access content—explore other articles or learn more about text-to-speech.
‌
Save

    Share this article

    Reminder, this is a Premium article and requires a subscription to read.

Metavivor Sue Wall-Cade has long been calling for better access to cancer drug Kadcyla. Now, Pharmac is planning to fund it. Photo / File

Metavivor Sue Wall-Cade has long been calling for better access to cancer drug Kadcyla. Now, Pharmac is planning to fund it. Photo / File

It has been exhausting, frustrating and incredibly hard but a Tauranga woman's fight for funding of a cancer wonder-drug has been heard.

Sue Wall-Cade is living with stage 4 metastatic breast cancer, also known as advanced breast cancer. She is a "metavivor" - a portmanteau of her terminal diagnosis and survivor.

On Wednesday, Pharmac announced plans to fund Kadcyla for HER-2 positive metastatic breast cancer patients such as Wall-Cade. Kadcyla is a life-prolonging drug believed to extend a person's life by two to three years.

READ MORE: Women's cancer fight reaches Parliament and Health select committee

The national drug funding agency will also look to fund Alecensa for positive advanced non-small cell lung cancer. Both drugs are anticipated to be made publicly available by December 1.

Advertisement
Advertise with NZME.

"I'm absolutely overjoyed. Absolutely thrilled for all the ladies who are HER-2 positive," Wall-Cade said.

"It's another tool in the toolbox to bash cancer. It's fantastic."

Sue Wall-Cade (left), pictured with fellow metavivor Tracy Barr-Smith. Both women are living with stage 4 metastatic breast cancer. Photo / File
Sue Wall-Cade (left), pictured with fellow metavivor Tracy Barr-Smith. Both women are living with stage 4 metastatic breast cancer. Photo / File

Wall-Cade has headed petitions calling for funding for Kadcyla, marched on Parliament with other metavivors, presented to the Health Select Committee, and written to MPs and the Prime Minister.

Advertisement
Advertise with NZME.

"It's nearly $10,000 a month. That's $3000 a week. It's just prohibitive. In Australia, it's $40. I mean, hello? It's just crazy."

READ MORE: Fighting cancer, and fighting the system

Discover more

Bay Paralympians to be celebrated in Tauranga

23 Jul 06:47 PM
Opinion

The Bay has lost a champion

26 Jul 06:00 PM

By chance or by choice, Bay residents are part of a global movement towards smaller families

26 Jul 10:32 PM

'Giving up alcohol for a month a small sacrifice': Top teetotaller

01 Aug 07:07 AM

Wall-Cade's fight has not been easy. She had been receiving chemotherapy but her body has now reached its limit with the treatment.

Kadcyla became Wall-Cade's only option. After recommendations from her oncologist and a second opinion, Wall-Cade had prepared to fund Kadcycla herself, beginning with selling things.

Pharmac's announcement comes following increased pressure by people such as Wall-Cade calling for better access to life-saving and life-prolonging drugs.

Earlier this year the Lung Cancer Foundation launched a petition saying five people died of the disease every day while a further six were diagnosed.

READ MORE: Women march on Parliament for funding of breast cancer medicines

Pharmac said it also planned to fund Ocrevus - a drug that treats relapsing remitting multiple sclerosis.

Advertisement
Advertise with NZME.

Life-saving drugs

Kadcyla, also known as T-DM1 or trastuzumab emtansine, is already in use and funded or subsidised in other OECD countries such as Australia and the United Kingdom.

Kadcyla, plus cancer drug Ibrance (the brand name for palbociclib), are considered to be "game-changers" by many breast cancer patients who say they potentially double the average survival rate of a patient's diagnosis.

More than 600 Kiwi women die each year from breast cancer, the nation's third most common form of cancer.

The agency is seeking public feedback on its proposal. All feedback received before the closing date will be considered by Pharmac's board (or its delegate) prior to making the final decision on this proposal.

READ MORE: Women plead for drugs to health select committee

Save

    Share this article

    Reminder, this is a Premium article and requires a subscription to read.

Latest from Bay of Plenty Times

Bay of Plenty Times

'Serious injuries': Crash closes highway

11 Jul 05:30 AM
Bay of Plenty Times

Mixed verdicts delivered for Tribesmen accused of murdering one of their own

11 Jul 05:00 AM
Bay of Plenty Times

'Hardly surviving': Sales fall after dairy raid

11 Jul 03:29 AM

From early mornings to easy living

sponsored
Advertisement
Advertise with NZME.

Latest from Bay of Plenty Times

'Serious injuries': Crash closes highway

'Serious injuries': Crash closes highway

11 Jul 05:30 AM

Emergency services are responding to a two-vehicle crash which has closed SH29.

Mixed verdicts delivered for Tribesmen accused of murdering one of their own

Mixed verdicts delivered for Tribesmen accused of murdering one of their own

11 Jul 05:00 AM
'Hardly surviving': Sales fall after dairy raid

'Hardly surviving': Sales fall after dairy raid

11 Jul 03:29 AM
Substation fault cuts power to thousands in Tauranga

Substation fault cuts power to thousands in Tauranga

11 Jul 03:01 AM
Solar bat monitors uncover secrets of Auckland’s night sky
sponsored

Solar bat monitors uncover secrets of Auckland’s night sky

NZ Herald
  • About NZ Herald
  • Meet the journalists
  • Newsletters
  • Classifieds
  • Help & support
  • Contact us
  • House rules
  • Privacy Policy
  • Terms of use
  • Competition terms & conditions
  • Our use of AI
Subscriber Services
  • Bay of Plenty Times e-edition
  • Manage your print subscription
  • Manage your digital subscription
  • Subscribe to Herald Premium
  • Subscribe to the Bay of Plenty Times
  • Gift a subscription
  • Subscriber FAQs
  • Subscription terms & conditions
  • Promotions and subscriber benefits
NZME Network
  • Bay of Plenty Times
  • The New Zealand Herald
  • The Northland Age
  • The Northern Advocate
  • Waikato Herald
  • Rotorua Daily Post
  • Hawke's Bay Today
  • Whanganui Chronicle
  • Viva
  • NZ Listener
  • Newstalk ZB
  • BusinessDesk
  • OneRoof
  • Driven Car Guide
  • iHeart Radio
  • Restaurant Hub
NZME
  • About NZME
  • NZME careers
  • Advertise with NZME
  • Digital self-service advertising
  • Book your classified ad
  • Photo sales
  • NZME Events
  • © Copyright 2025 NZME Publishing Limited
TOP